Paper34769263
Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer.
Minnelli C and 5 others. Int J Mol Sci, 2021. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer. Papers, record 34769263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34769263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Catechin | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasm Proteins | Major topic |
| Signal Transduction | Major topic |
| A549 Cells | |
| ErbB Receptors | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| n.25234 | Italian Association for Cancer Research | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19692680 | Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19692680 | PubMed |
| 2 | 22769244 | Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22769244 | PubMed |
| 3 | 25997717 | Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance. | Int J Oncol | 2015 | https://conductscience.org/library/papers/25997717 | PubMed |
| 4 | 19002495 | Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling. | J Cancer Res Clin Oncol | 2009 | https://conductscience.org/library/papers/19002495 | PubMed |
| 5 | 28521301 | Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC). | Oncotarget | 2017 | https://conductscience.org/library/papers/28521301 | PubMed |
| 6 | 32660101 | Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. | Molecules | 2020 | https://conductscience.org/library/papers/32660101 | PubMed |
| 7 | 15284455 | Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. | Science | 2004 | https://conductscience.org/library/papers/15284455 | PubMed |
| 8 | 25835573 | The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. | Expert Opin Drug Discov | 2015 | https://conductscience.org/library/papers/25835573 | PubMed |
| 9 | 20874002 | MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. | Cancer Invest | 2010 | https://conductscience.org/library/papers/20874002 | PubMed |
| 10 | 26728462 | Mechanisms and Functions of Vinculin Interactions with Phospholipids at Cell Adhesion Sites. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26728462 | PubMed |
| 11 | 23589165 | Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway. | Oncol Rep | 2013 | https://conductscience.org/library/papers/23589165 | PubMed |
| 12 | 22613835 | The C-terminal tail domain of metavinculin, vinculin's splice variant, severs actin filaments. | J Cell Biol | 2012 | https://conductscience.org/library/papers/22613835 | PubMed |
| 13 | 23201840 | Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. | Nutrients | 2012 | https://conductscience.org/library/papers/23201840 | PubMed |
| 14 | 17545512 | The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17545512 | PubMed |
| 15 | 31440060 | EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31440060 | PubMed |
| 16 | 17557195 | Cell motility and cytoskeletal regulation in invasion and metastasis. | J Mammary Gland Biol Neoplasia | 2007 | https://conductscience.org/library/papers/17557195 | PubMed |
| 17 | 30947597 | Vinculin expression in non-small cell lung cancer. | J Int Med Res | 2020 | https://conductscience.org/library/papers/30947597 | PubMed |
| 18 | 31370225 | Synthesis, Characterization and Antioxidant Properties of a New Lipophilic Derivative of Edaravone. | Antioxidants (Basel) | 2019 | https://conductscience.org/library/papers/31370225 | PubMed |
| 19 | 15864276 | ERBB receptors and cancer: the complexity of targeted inhibitors. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15864276 | PubMed |
| 20 | 24366444 | Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway. | Oncol Rep | 2014 | https://conductscience.org/library/papers/24366444 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42292663 | Metal-polyphenol nanomedicines for malignant tumor therapy. | Front Chem | 2026 | https://conductscience.org/library/papers/42292663 | PubMed |
| 42193064 | Agro-Industrial Plant Biomass as a Sustainable Source of Anticancer Polyphenols: Molecular Mechanisms and Future Perspectives. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42193064 | PubMed |
| 42075806 | Bioactive Natural Compounds in Triple-Negative Breast Cancer: Molecular Targets and Therapeutic Perspectives. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42075806 | PubMed |
| 41971100 | Natural compounds for non-small cell lung cancer treatment: focus on the EGFR signaling pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41971100 | PubMed |
| 41683202 | Effects of Epigallocatechin Gallate Against Lung Cancer: Mechanisms of Action and Therapeutic Potential. | Nutrients | 2026 | https://conductscience.org/library/papers/41683202 | PubMed |
| 41599929 | Dietary (-)-Epigallocatechin Gallate (EGCG): State-of-the-Art Advances in Bioactivities, Bioavailability Enhancement Strategies, and Applications in Nutrition and Health. | Nutrients | 2026 | https://conductscience.org/library/papers/41599929 | PubMed |
| 40867905 | Limited Chemopreventive Effects of Oral Administration of Polyphenol-60 from Green Tea in the MNU-Induced Rat Mammary Tumor Model. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40867905 | PubMed |
| 40755497 | Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40755497 | PubMed |
| 40728967 | The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40728967 | PubMed |
| 40642602 | Splenic infarction secondary to multi-site thrombosis in lung adenocarcinoma with EGFR-L858R mutation: A case report. | Oncol Lett | 2025 | https://conductscience.org/library/papers/40642602 | PubMed |
| 40427676 | Deciphering the Regulatory Potential of Antioxidant and Electron-Shuttling Bioactive Compounds in Oolong Tea. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40427676 | PubMed |
| 40417000 | Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment. | Open Life Sci | 2025 | https://conductscience.org/library/papers/40417000 | PubMed |
| 40256718 | Natural polyphenols as novel interventions for aging and age-related diseases: Exploring efficacy, mechanisms of action and implications for future research. | Chin Herb Med | 2025 | https://conductscience.org/library/papers/40256718 | PubMed |
| 40161336 | EGCG's anticancer potential unveiled: triggering apoptosis in lung cancer cell lines through in vitro investigation. | PeerJ | 2025 | https://conductscience.org/library/papers/40161336 | PubMed |
| 39858410 | Epigenetic Properties of Compounds Contained in Functional Foods Against Cancer. | Biomolecules | 2024 | https://conductscience.org/library/papers/39858410 | PubMed |
| 39529343 | Mechanism of the combined action of green tea polyphenols and concurrent radiochemotherapy in regulating GSK-3β to treat non-small cell lung cancer through the Wnt∕β-catenin pathway. | Rom J Morphol Embryol | 2024 | https://conductscience.org/library/papers/39529343 | PubMed |
| 39021869 | Exploring the effect of epigallocatechin gallate on non small cell lung cancer. | Int J Biochem Mol Biol | 2024 | https://conductscience.org/library/papers/39021869 | PubMed |
| 38840243 | Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38840243 | PubMed |
| 38543009 | Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. | Molecules | 2024 | https://conductscience.org/library/papers/38543009 | PubMed |
| 38275516 | Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease. | Brain Sci | 2024 | https://conductscience.org/library/papers/38275516 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34769263
GET https://conductscience.org/api/papers/v1/34769263/references?page=2